NOXXON ISSUES TRANCHE OF ODIRNANE BONDS

NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has issued another tranche of the ODIRNANE bonds (undated bonds…

1 Min
More

Blood test enables reading out the internal clock

With a new blood test, researchers at the Charité – Universitätsmedizin Berlin can determine the state of the internal clock of a person. Once the internal rhythm of patient is known, drugs could be administered at particular times of day making them…

2 Min
More

Restore Health – Therapies that cure

The European Commission (EC) announced that the FET Flagship RESTORE, which was initiated by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), has been selected to enter the next phase of the FET Flagship competition. A successful FET…

2 Min
More

Berlin Health Innovations invests in 18 pioneering innovations

The validation fund of Berlin Health Innovations in cooperation with SPARK Berlin is entering its first round. 18 selected teams from the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz…

2 Min
More

ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform

Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate

2 Min
More

Thinking beyond the lab: Call for improved ethics in preclinical research

Joint press release by Berlin Institute of Health and Charité – Universtätsmedizin Berlin

 

Avoidable errors in preclinical research often result in patients being subjected to studies where the risks are high and the chances of success are low.…

4 Min
More

Eckert & Ziegler is Manufacturing Partner for Bayer’s Innovative Targeted Thorium Conjugates in Europe

Eckert & Ziegler AG, a specialist for scientific, medical, and industrial applications of radioisotopes, has been selected as manufacturing partner for clinical supply of Bayer's innovative Targeted Thorium Conjugates (TTCs) in Europe. TTCs are a…

1 Min
More

Identification of a novel hepatitis B virus in capuchin monkeys

Researchers from Charité – Universitätsmedizin Berlin and Justus-Liebig-Universität (JLU) Gießen have identified a new hepatitis B virus in Brazilian capuchin monkeys. Their research, which offers insights into the evolution of hepatitis B viruses in…

2 Min
More

New radiological procedure for the diagnosis of liver disease

Ultrasound technology may replace the need for liver biopsies

2 Min
More
Show more items